Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duncan T Njenda

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Virology|February 15, 2019
HIV-1 Subtype C with PYxE Insertion Has Enhanced Binding of Gag-p6 to Host Cell Protein ALIX and Increased Replication FitnessRobert van Domselaar, Duncan T Njenda, Rohit Rao, et al.
The Journal of Antimicrobial Chemotherapy|July 28, 2018
Antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypesDuncan T Njenda, Shambhu G Aralaguppe, Kamalendra Singh, et al.
AIDS (London, England)|December 15, 2017
Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypesUjjwal Neogi, Kamalendra Singh, Shambhu G Aralaguppe, et al.
AIDS (London, England)|November 27, 2018
Strain-specific effect on biphasic DNA binding by HIV-1 integraseKyle J Hill, Leonard C Rogers, Duncan T Njenda, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Virology|February 15, 2019
HIV-1 Subtype C with PYxE Insertion Has Enhanced Binding of Gag-p6 to Host Cell Protein ALIX and Increased Replication FitnessRobert van Domselaar, Duncan T Njenda, Rohit Rao, et al.
The Journal of Antimicrobial Chemotherapy|July 28, 2018
Antiretroviral potency of 4'-ethnyl-2'-fluoro-2'-deoxyadenosine, tenofovir alafenamide and second-generation NNRTIs across diverse HIV-1 subtypesDuncan T Njenda, Shambhu G Aralaguppe, Kamalendra Singh, et al.
AIDS (London, England)|December 15, 2017
Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypesUjjwal Neogi, Kamalendra Singh, Shambhu G Aralaguppe, et al.
AIDS (London, England)|November 27, 2018
Strain-specific effect on biphasic DNA binding by HIV-1 integraseKyle J Hill, Leonard C Rogers, Duncan T Njenda, et al.
Pageof 1